Information Provided By:
Fly News Breaks for February 6, 2020
REGN
Feb 6, 2020 | 11:53 EDT
Piper Sandler analyst Christopher Raymond said he views early strength in shares of Regeneron today as "appropriate" given the company's strong Q4 results and indications of confidence in 2020 consensus. While no yearly guidance was provided, management seems increasingly comfortable providing "enhanced guidance" going forward, said Raymond, who sees a "catalyst schedule filled with meaningful data" in 2020. He maintains an Overweight rating and $435 price target on Regeneron shares.
News For REGN From the Last 2 Days
REGN
REGN
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.